$CPHD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CEPHEID.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CEPHEID. Get notifications about new insider transactions in CEPHEID for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 15 16 ... 19 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Buy | M | 0.00 | 1,050 | 0 | 26,338 | 25.3 K to 26.3 K (+4.15 %) |
| Apr 25 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 1,563 | 0 | 12,500 | |
| Apr 25 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 4,250 | 0 | 12,750 | |
| Apr 25 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Payment of Exercise | F | 38.42 | 816 | 31,351 | 32,816 | 33.6 K to 32.8 K (-2.43 %) |
| Apr 25 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Buy | M | 0.00 | 1,563 | 0 | 33,632 | 32.1 K to 33.6 K (+4.87 %) |
| Apr 25 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Payment of Exercise | F | 37.95 | 2,218 | 84,173 | 32,069 | 34.3 K to 32.1 K (-6.47 %) |
| Apr 25 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Buy | M | 0.00 | 4,250 | 0 | 34,287 | 30 K to 34.3 K (+14.15 %) |
| Apr 23 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Option Exercise | M | 9.18 | 134,799 | 1,237,455 | 0 | |
| Apr 23 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Sell | S | 37.51 | 134,799 | 5,056,027 | 30,037 | 164.8 K to 30 K (-81.78 %) |
| Apr 23 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Buy | M | 9.18 | 134,799 | 1,237,455 | 164,836 | 30 K to 164.8 K (+448.78 %) |
| Apr 04 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 625 | 0 | 6,875 | |
| Apr 04 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 36.61 | 235 | 8,603 | 10,687 | 10.9 K to 10.7 K (-2.15 %) |
| Apr 04 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 625 | 0 | 10,922 | 10.3 K to 10.9 K (+6.07 %) |
| Mar 25 2013 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 38.28 | 3,000 | 114,837 | 400,800 | 403.8 K to 400.8 K (-0.74 %) |
| Feb 25 2013 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 36.42 | 3,000 | 109,273 | 682,300 | 685.3 K to 682.3 K (-0.44 %) |
| Mar 19 2013 | CPHD | CEPHEID | Jacon Philippe | EVP, Emerging Marke ... | Option Exercise | A | 39.13 | 39,150 | 1,531,940 | 39,150 | |
| Mar 19 2013 | CPHD | CEPHEID | Jacon Philippe | EVP, Emerging Marke ... | Option Exercise | A | 0.00 | 4,350 | 0 | 4,350 | |
| Feb 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 15,000 | 110,700 | 0 | |
| Feb 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 36.13 | 15,000 | 541,994 | 3,441 | 18.4 K to 3.4 K (-81.34 %) |
| Feb 25 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 15,000 | 110,700 | 18,441 | 3.4 K to 18.4 K (+435.92 %) |
| Feb 25 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 4.30 | 10 | 43 | 0 | |
| Feb 25 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Sell | S | 35.53 | 10 | 355 | 8,162 | 8.2 K to 8.2 K (-0.12 %) |
| Feb 25 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 4.30 | 10 | 43 | 8,172 | 8.2 K to 8.2 K (+0.12 %) |
| Feb 12 2013 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 36.11 | 412 | 14,877 | 2,833 | 2.4 K to 2.8 K (+17.02 %) |
| Feb 12 2013 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 36.11 | 573 | 20,691 | 224,729 | 224.2 K to 224.7 K (+0.26 %) |
| Feb 12 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | M | 9.18 | 10,000 | 91,800 | 0 | |
| Feb 12 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 36.11 | 530 | 19,138 | 25,288 | 24.8 K to 25.3 K (+2.14 %) |
| Feb 12 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Sell | S | 36.07 | 3,054 | 110,156 | 24,758 | 27.8 K to 24.8 K (-10.98 %) |
| Feb 12 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Payment of Exercise | F | 36.07 | 2,546 | 91,833 | 27,812 | 30.4 K to 27.8 K (-8.39 %) |
| Feb 12 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Buy | M | 9.18 | 10,000 | 91,800 | 30,358 | 20.4 K to 30.4 K (+49.12 %) |
| Feb 12 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | M | 9.18 | 12,500 | 114,750 | 0 | |
| Feb 12 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 36.11 | 390 | 14,083 | 77,732 | 77.3 K to 77.7 K (+0.50 %) |
| Feb 12 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Sell | S | 36.05 | 12,500 | 450,675 | 77,342 | 89.8 K to 77.3 K (-13.91 %) |
| Feb 12 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Buy | M | 9.18 | 12,500 | 114,750 | 89,842 | 77.3 K to 89.8 K (+16.16 %) |
| Feb 06 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 9.11 | 38,400 | 349,824 | 0 | |
| Feb 06 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Sell | S | 36.20 | 38,400 | 1,390,222 | 8,162 | 46.6 K to 8.2 K (-82.47 %) |
| Feb 06 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 9.11 | 38,400 | 349,824 | 46,562 | 8.2 K to 46.6 K (+470.47 %) |
| Jan 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 0.00 | 312 | 0 | 1,563 | |
| Jan 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Payment of Exercise | F | 36.09 | 137 | 4,944 | 7,476 | 7.6 K to 7.5 K (-1.80 %) |
| Jan 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 0.00 | 312 | 0 | 7,613 | 7.3 K to 7.6 K (+4.27 %) |
| Jan 30 2013 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 338 | 0 | 1,693 | |
| Jan 30 2013 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 36.09 | 149 | 5,377 | 14,777 | 14.9 K to 14.8 K (-1.00 %) |
| Jan 30 2013 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 338 | 0 | 14,926 | 14.6 K to 14.9 K (+2.32 %) |
| Jan 30 2013 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,250 | 0 | 6,250 | |
| Jan 30 2013 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 36.09 | 477 | 17,215 | 29,932 | 30.4 K to 29.9 K (-1.57 %) |
| Jan 30 2013 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,250 | 0 | 30,409 | 29.2 K to 30.4 K (+4.29 %) |
| Jan 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 1,693 | |
| Jan 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 36.09 | 149 | 5,377 | 3,359 | 3.5 K to 3.4 K (-4.25 %) |
| Jan 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 3,508 | 3.2 K to 3.5 K (+10.66 %) |
| Jan 30 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 1,250 | 0 | 6,250 | |
| Jan 30 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 36.09 | 459 | 16,565 | 10,297 | 10.8 K to 10.3 K (-4.27 %) |
| Jan 30 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 1,250 | 0 | 10,756 | 9.5 K to 10.8 K (+13.15 %) |
| Jan 30 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 37.31 | 147 | 5,485 | 20,000 | 20.1 K to 20 K (-0.73 %) |
| Jan 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 0.00 | 250 | 0 | 2,250 | |
| Jan 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Payment of Exercise | F | 37.83 | 110 | 4,161 | 7,301 | 7.4 K to 7.3 K (-1.48 %) |
| Jan 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 0.00 | 250 | 0 | 7,411 | 7.2 K to 7.4 K (+3.49 %) |
| Jan 28 2013 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 312 | 0 | 2,813 | |
| Jan 28 2013 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 37.83 | 137 | 5,183 | 14,588 | 14.7 K to 14.6 K (-0.93 %) |
| Jan 28 2013 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 312 | 0 | 14,725 | 14.4 K to 14.7 K (+2.16 %) |
| Jan 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 2,718 | |
| Jan 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 37.83 | 133 | 5,031 | 3,170 | 3.3 K to 3.2 K (-4.03 %) |
| Jan 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 3,303 | 3 K to 3.3 K (+10.06 %) |
| Jan 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 0.00 | 237 | 0 | 2,133 | |
| Jan 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 31.49 | 6,250 | 196,781 | 27,875 | |
| Jan 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Payment of Exercise | F | 37.83 | 90 | 3,405 | 20,147 | 20.2 K to 20.1 K (-0.44 %) |
| Jan 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 0.00 | 237 | 0 | 20,237 | 20 K to 20.2 K (+1.19 %) |
| Jan 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 38.00 | 6,250 | 237,500 | 20,000 | 26.3 K to 20 K (-23.81 %) |
| Jan 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 31.49 | 6,250 | 196,781 | 26,250 | 20 K to 26.3 K (+31.25 %) |
| Jan 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 250 | 0 | 2,250 | |
| Jan 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 37.83 | 92 | 3,480 | 9,506 | 9.6 K to 9.5 K (-0.96 %) |
| Jan 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 250 | 0 | 9,598 | 9.3 K to 9.6 K (+2.67 %) |
| Jan 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,562 | 0 | 14,063 | |
| Jan 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 37.83 | 685 | 25,914 | 29,159 | 29.8 K to 29.2 K (-2.30 %) |
| Jan 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,562 | 0 | 29,844 | 28.3 K to 29.8 K (+5.52 %) |
| Jan 28 2013 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 35.20 | 3,000 | 105,599 | 685,300 | 688.3 K to 685.3 K (-0.44 %) |
| Jan 07 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
| Jan 07 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 34.09 | 1,172 | 39,953 | 9,348 | 10.5 K to 9.3 K (-11.14 %) |
| Jan 07 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 2,500 | 0 | 10,520 | 8 K to 10.5 K (+31.17 %) |
| Jan 03 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and Ge ... | Option Exercise | A | 0.00 | 4,166 | 0 | 4,166 | |
| Jan 03 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and Ge ... | Option Exercise | A | 35.48 | 37,500 | 1,330,500 | 37,500 | |
| Jan 03 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | A | 0.00 | 28,750 | 0 | 28,750 | |
| Jan 03 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | A | 35.48 | 28,750 | 1,020,050 | 28,750 | |
| Jan 03 2013 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| Jan 03 2013 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 1,625 | 0 | 0 | |
| Jan 03 2013 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 33.86 | 1,932 | 65,418 | 4,596 | 6.5 K to 4.6 K (-29.60 %) |
| Jan 03 2013 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 4,125 | 0 | 6,528 | 2.4 K to 6.5 K (+171.66 %) |
| Dec 27 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 33.06 | 3,000 | 99,193 | 688,300 | 691.3 K to 688.3 K (-0.43 %) |
| Dec 19 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | M | 11.85 | 12,500 | 148,125 | 0 | |
| Dec 19 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | M | 7.35 | 7,500 | 55,125 | 0 | |
| Dec 19 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | M | 9.18 | 12,500 | 114,750 | 0 | |
| Dec 19 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Option Exercise | M | 5.20 | 7,500 | 39,000 | 0 | |
| Dec 19 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Buy | M | 11.85 | 12,500 | 148,125 | 224,156 | 211.7 K to 224.2 K (+5.91 %) |
| Dec 19 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Buy | M | 7.35 | 7,500 | 55,125 | 211,656 | 204.2 K to 211.7 K (+3.67 %) |
| Dec 19 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Buy | M | 9.18 | 12,500 | 114,750 | 204,156 | 191.7 K to 204.2 K (+6.52 %) |
| Dec 19 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Buy | M | 5.20 | 7,500 | 39,000 | 191,656 | 184.2 K to 191.7 K (+4.07 %) |
| Nov 27 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 9.18 | 4,778 | 43,862 | 7,722 | |
| Nov 27 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 32.00 | 4,778 | 152,898 | 89,125 | 93.9 K to 89.1 K (-5.09 %) |
| Nov 27 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 9.18 | 4,778 | 43,862 | 93,903 | 89.1 K to 93.9 K (+5.36 %) |
| Nov 27 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.83 | 3,000 | 95,494 | 691,300 | 694.3 K to 691.3 K (-0.43 %) |
| Nov 29 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 11.85 | 12,500 | 148,125 | 0 | |
| Nov 29 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Option Exercise | M | 9.18 | 7,722 | 70,888 | 0 | |
| Nov 29 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.80 | 20,222 | 643,149 | 89,125 | 109.3 K to 89.1 K (-18.49 %) |
| Nov 29 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 11.85 | 12,500 | 148,125 | 109,347 | 96.8 K to 109.3 K (+12.91 %) |
| Nov 29 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Buy | M | 9.18 | 7,722 | 70,888 | 96,847 | 89.1 K to 96.8 K (+8.66 %) |
| Nov 14 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 29.45 | 505 | 14,872 | 2,421 | 1.9 K to 2.4 K (+26.36 %) |
| Nov 14 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 29.45 | 703 | 20,703 | 184,156 | 183.5 K to 184.2 K (+0.38 %) |
| Nov 14 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 29.45 | 482 | 14,195 | 77,342 | 76.9 K to 77.3 K (+0.63 %) |
| Nov 14 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 29.45 | 652 | 19,201 | 20,358 | 19.7 K to 20.4 K (+3.31 %) |
| Oct 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 313 | 0 | 1,875 | |
| Oct 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Payment of Exercise | F | 30.46 | 147 | 4,478 | 7,161 | 7.3 K to 7.2 K (-2.01 %) |
| Oct 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 313 | 0 | 7,308 | 7 K to 7.3 K (+4.47 %) |
| Oct 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 339 | 0 | 2,031 | |
| Oct 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 30.46 | 159 | 4,843 | 14,413 | 14.6 K to 14.4 K (-1.09 %) |
| Oct 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 339 | 0 | 14,572 | 14.2 K to 14.6 K (+2.38 %) |
| Oct 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 2,031 | |
| Oct 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 30.46 | 159 | 4,843 | 3,001 | 3.2 K to 3 K (-5.03 %) |
| Oct 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 3,160 | 2.8 K to 3.2 K (+12.02 %) |
| Oct 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 1,250 | 0 | 7,500 | |
| Oct 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 250 | 0 | 2,500 | |
| Oct 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 30.46 | 584 | 17,789 | 8,020 | 8.6 K to 8 K (-6.79 %) |
| Oct 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 1,250 | 0 | 8,604 | 7.4 K to 8.6 K (+17.00 %) |
| Oct 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 31.10 | 117 | 3,639 | 7,354 | 7.5 K to 7.4 K (-1.57 %) |
| Oct 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 250 | 0 | 7,471 | 7.2 K to 7.5 K (+3.46 %) |
| Oct 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 271 | 0 | 1,625 | |
| Oct 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 30.46 | 127 | 3,868 | 2,403 | 2.5 K to 2.4 K (-5.02 %) |
| Oct 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 271 | 0 | 2,530 | 2.3 K to 2.5 K (+12.00 %) |
| Oct 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,250 | 0 | 7,500 | |
| Oct 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 30.46 | 584 | 17,789 | 28,282 | 28.9 K to 28.3 K (-2.02 %) |
| Oct 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,250 | 0 | 28,866 | 27.6 K to 28.9 K (+4.53 %) |
| Oct 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 344 | 0 | 2,063 | |
| Oct 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Payment of Exercise | F | 30.46 | 161 | 4,904 | 3,428 | 3.6 K to 3.4 K (-4.49 %) |
| Oct 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 344 | 0 | 3,589 | 3.2 K to 3.6 K (+10.60 %) |
| Oct 29 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 250 | 0 | 2,500 | |
| Oct 29 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Payment of Exercise | F | 31.10 | 117 | 3,639 | 6,995 | 7.1 K to 7 K (-1.65 %) |
| Oct 29 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 250 | 0 | 7,112 | 6.9 K to 7.1 K (+3.64 %) |
| Oct 29 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 250 | 0 | 2,500 | |
| Oct 29 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Payment of Exercise | F | 31.10 | 117 | 3,639 | 6,995 | 7.1 K to 7 K (-1.65 %) |
| Oct 29 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 250 | 0 | 7,112 | 6.9 K to 7.1 K (+3.64 %) |
| Oct 29 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 313 | 0 | 3,125 | |
| Oct 29 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 31.10 | 147 | 4,572 | 14,233 | 14.4 K to 14.2 K (-1.02 %) |
| Oct 29 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 313 | 0 | 14,380 | 14.1 K to 14.4 K (+2.23 %) |
| Oct 29 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 3,020 | |
| Oct 29 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 31.10 | 141 | 4,385 | 2,821 | 3 K to 2.8 K (-4.76 %) |
| Oct 29 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 2,962 | 2.7 K to 3 K (+11.35 %) |
| Oct 29 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 250 | 0 | 2,500 | |
| Oct 29 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 31.10 | 117 | 3,639 | 2,259 | 2.4 K to 2.3 K (-4.92 %) |
| Oct 29 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 250 | 0 | 2,376 | 2.1 K to 2.4 K (+11.76 %) |
| Oct 29 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 250 | 0 | 2,500 | |
| Oct 29 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 31.10 | 117 | 3,639 | 2,259 | 2.4 K to 2.3 K (-4.92 %) |
| Oct 29 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 250 | 0 | 2,376 | 2.1 K to 2.4 K (+11.76 %) |